NEUMORA THERAPEUTICS, INC. (NMRA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading NMRA…

NEUMORA THERAPEUTICS, INC. (NMRA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

NEUMORA THERAPEUTICS, INC.

NMRA · CIK 1885522

4 · Aug 21, 2026 · Director, President & CEO Pinto Joshua was granted 500K Stock Option (Right to Buy)

4

Director, President & CEO Pinto Joshua was granted 500K Stock Option (Right to Buy)

Filed: Aug 21, 2026
Period: Aug 20, 2026
Accession: 0001610717-26-000381
Filer: Neumora Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/form4.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4form4.xml
Open SEC.gov